Safety and Efficacy of Upadacitinib in Patients with Rheumatoid Arthritis Refractory to Biologic DMARDs: Results Through Week 216 from the SELECT-CHOICE Study. - Rubbert-Roth, Andrea; Kato, Koji; Haraoui, Boulos; Rischmueller, Maureen; Liu, Yanxi; Khan, Nasser; Camp, Heidi S.; Xavier, Ricardo M. (Rheumatology & Therapy, 2024)